allintitle:semaglutide vs ozempic Semaglutide for Weight Loss Guide Basaglar vs Ozempic 2026: Insulin

Consistent monitoring helps ensure safety

See below for the text of the two pages of the notebook

Supply Shortages Pharmacies worldwide have reported stock-outs of Ozempic and Wegovy, impacting diabetic and obese patients who genuinely need these medications for disease management

Acceptable Documentation Sources Medication reconciliation list showing insulin as an active current medication Provider note explicitly stating patient is on long-term insulin therapy or insulin-controlled Type 2 diabetes Prescription record for insulin within the encounter date or active medication review Problem list entry indicating insulin-dependent or insulin-controlled diabetes What Documentation Is Insufficient A history of insulin use without confirmation it is ongoing at this encounter A notation that insulin was administered during the encounter without evidence of an ongoing regimen Discharge summary from a prior hospitalization only, with no current medication confirmation Practices that use digital intake forms can embed medication status prompts that capture insulin use at every visit check-in, creating a structured data point in the record without requiring the provider to manually note it in the encounter documentation

Heo et al., 2020)